Bright Minds Biosciences ... (DRUG)
NASDAQ: DRUG
· Real-Time Price · USD
42.34
-3.21 (-7.05%)
At close: Aug 19, 2025, 12:00 PM
-7.05% (1D)
| Bid | 42.28 |
| Market Cap | 299.9M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.44M |
| EPS (ttm) | -0.99 |
| PE Ratio (ttm) | -42.77 |
| Forward PE | -7.91 |
| Analyst | Buy |
| Ask | 42.79 |
| Volume | 24,318 |
| Avg. Volume (20D) | 46,493 |
| Open | 46.13 |
| Previous Close | 45.55 |
| Day's Range | 42.00 - 46.13 |
| 52-Week Range | 0.94 - 79.02 |
| Beta | 0.17 |
About DRUG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRUG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+3.36%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
8 months ago
-1.24%
Bright Minds Biosciences shares are trading higher after Baird initiated coverage on the stock with an Outperform rating and announced a price target of $75.
